Innovation Pharmaceuticals (IPIX) Stock Price, News & Analysis

Company Overview

Innovation Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to the development of novel antimicrobial compounds and innate defense regulators (IDRs). The company’s research focuses on synthetic peptide mimetics designed to harness and amplify the body’s natural immune response, offering an alternative approach to traditional antibiotics and addressing the growing challenge of drug-resistant bacterial infections.

At the core of Innovation Pharmaceuticals’ pipeline is brilacidin, a synthetic host defense peptide mimetic undergoing clinical evaluation for acute bacterial skin and skin structure infections and respiratory indications. Utilizing proprietary chemistry platforms, the company seeks to advance brilacidin and additional IDR candidates through human trials, with the goal of securing strategic partnerships or licensing agreements for late-stage development and commercialization. This strategy underscores its commitment to tackling unmet medical needs in infectious and inflammatory diseases.

Headquartered in San Diego, California, Innovation Pharmaceuticals collaborates with contract development and manufacturing organizations, as well as academic research centers across North America. The company is guided by an executive leadership team experienced in biopharmaceutical R&D, regulatory strategy, and alliance management. Through its blend of in-house discovery and external partnerships, Innovation Pharmaceuticals aims to bring innovative anti-infective therapies to patients around the globe.

Key Stats

• Today's Range: $0.0010 to $0.0030
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.05
• Volume: 214,230 shs
• Average Volume: 138,518 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:IPIX
• CIK: 1355250
• Web: www.cellceutix.com
• Phone: (978) 921-4125
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A